Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ACTRN12626000627358) titled 'Adjunctive Fludrocortisone with transcriptome evaluation in critically ill adults with septic shock- FLUDRO-SHOCK Trial' on May 22.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: The George Institute for Global Health
Condition:
Septic shock
Septic shock
Inflammatory and Immune System - Other inflammatory or immune system disorders
Intervention:
Participants receiving intravenous hydrocortisone at a daily dose of 200 mg/day as adjunctive treatment fo...